IRIDEX Corporation: updates and filings

IRIXNASDAQHealthcare · Electromedical & Electrotherapeutic Apparatus

Price

$0.47

November 19, 2026Market cap $8.1M

What Ploutos Investor adds for IRIDEX

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 33% since Nov 17, 2026, when the 10-Q these figures come from was filed ($0.70 then, $0.47 on Nov 19, 2026). The figures date from before that move.10-Q

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 95 daysAround Feb 23, 2027 · for Q4 2026

last Nov 17, 2026next Feb 23, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Apr 2, 2026 latest annualNov 17, 2026 latest quarterly
  • Nov 17, 2026Quarterly reportfor the period to Oct 3, 2026
    Form10-Q
  • Nov 17, 2026Results of operations
    Form8-K
  • Sep 2, 2026Delisting notice
    Form8-K
  • Aug 18, 2026Quarterly reportfor the period to Jul 4, 2026
    Form10-Q
  • Aug 18, 2026Results of operations
    Form8-K
  • Jul 16, 2026Shareholder vote, Regulation FD disclosure
    Form8-K
  • Jul 13, 2026Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • Jun 18, 2026Other material events
    Form8-K
  • Jun 1, 2026Conflict minerals report
    FormSD
  • May 19, 2026Quarterly reportfor the period to Apr 4, 2026
    Form10-Q
  • May 19, 2026Results of operations
    Form8-K
  • Apr 24, 2026Annual report to shareholdersfor the period to Jan 3, 2026
    FormARS
  • Apr 24, 2026Additional annual meeting material
    FormDEFA14A
  • Apr 24, 2026Annual meeting proxy statement
    FormDEF 14A
  • Apr 3, 2026Filing (amendment)
    FormD/A
  • Apr 2, 2026Annual reportfor the period to Jan 3, 2026
    Form10-K
  • Mar 26, 2026Results of operations
    Form8-K
  • Mar 13, 2026Material agreement entered, new material financial obligation
    Form8-K
  • Jan 12, 2026Results of operations
    Form8-K
  • Jan 8, 2026Over-5% holder statement (active)
    FormSCHEDULE 13D
  • Dec 11, 2025Regulation FD disclosure
    Form8-K
  • Nov 12, 2025Quarterly reportfor the period to Sep 27, 2025
    Form10-Q
  • Nov 12, 2025Results of operations
    Form8-K
  • Sep 9, 2025Other material events
    Form8-K
  • Aug 12, 2025Quarterly reportfor the period to Jun 28, 2025
    Form10-Q

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Aug 14, 1996.

The full analysis

What do IRIDEX's filings show?

The filings are where every one of IRIDEX's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.